← All indications
Pharyngitis
Inflammation of the throat (PHARYNX).
Subtype terms (3)
More specific conditions that are subtypes of Pharyngitis in the MeSH hierarchy.
- Nasopharyngitis
5 drugs (1 approved, 4 experimental)
- Retropharyngeal Abscess
1 drug approved
- Tonsillitis
62 drugs (54 approved, 8 experimental)
Drugs by status
Approved for this indication (22)
Phase 4 trials (18)
Phase 3 trials (16)
Phase 2 trials (9)
Phase 1 trials (3)
Organizations
Organization Involved with Phase 4 Indications (21)
- Bayer
- Medice Arzneimittel Pütter GmbH & Co KG
- Boehringer Ingelheim
- Albany Medical College
- Chang Gung University
- Lund University
- Northwestern University
- Pamukkale University
- Seoul National University
- University of Jordan
- B.P. Koirala Institute of Health Sciences
- Umea University
- University of Ankara
- University of Munster
- Catholic University of Sacred Heart, Rome
- Linkoping University
- Keimyung University
- Ostfold University
- University of Geneva
- Government of Sweden
- Gertrude Von Meissner Foundation
Organization Involved with Phase 3 Indications (22)
- Pierre Fabre
- BioCryst
- Grunenthal
- Sandoz
- Sanofi
- Novartis
- Bioforce AG
- SocraTec R&D GmbH
- Middlebrook Pharmaceuticals
- Azad University
- Kocaeli University
- Zagazig University
- Istanbul University
- Prince of Songkla University
- Reckitt Benckiser Pharmaceutical
- Isfahan University
- Janssen Pharmaceutica NV
- B.I. South Africa (Pty.) Ltd.
- Department of Health and Human Services
- MonitorCRO
- Johnson and Johnson
- Oman Medical Board Specialty (OMSB)
Organization Involved with Phase 2 Indications (4)
Organization Involved with Phase 1 Indications (13)
- Telethon Kids Institute
- University of Melbourne
- University of Tennessee
- Tel Aviv University
- University of Auckland
- Nucleus Network Ltd
- University of Queensland
- Free University of Brussels
- National Health and Medical Research Council, Australia
- University of Wollongong
- The Peter Doherty Institute
- Griffith University
- Murdoch University
Organization Involved with Other Experimental Indications (22)
- World Health Organization
- Cairo University
- Johns Hopkins University
- Mongi Slim Hospital
- Saint-Joseph University
- Sichuan University
- University of Malaya
- University of Saskatchewan
- University of Vermont
- Yonsei University
- Taipei Medical University
- Federal University of Rio de Janeiro
- Antalya Training and Govermental Hospital
- Yeungnam University
- Soonchunhyang University
- Moorgreen Hospital, Southampton
- Johannes Gutenburg University
- United States Agency for International Development
- University Hospital for Infectious Diseases, Croatia
- Derince Training and Research Hospital
- Karabuk University
- Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital